Pharmanutra S.p.A. (BIT: PHN)

Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17.82	18.93	22.05	29.41	16.46	13.75
Short-Term Investments	-	6.19	4.81	4.53	4.35	5.08
Cash & Short-Term Investments	17.82	25.12	26.86	33.94	20.8	18.83
Cash Growth	21.04%	-6.49%	-20.86%	63.14%	10.50%	18.92%
Accounts Receivable	24.54	19.22	21.65	16.67	15.05	15.03
Other Receivables	0.54	2.7	2.12	0.99	1.87	0.97
Receivables	25.08	21.92	23.77	17.66	16.92	15.99
Inventory	7.97	8.17	5.26	2.87	1.89	1.85
Prepaid Expenses	-	1.06	0.93	0.15	-	0.14
Other Current Assets	12.55	2.42	1.9	0.9	0.79	0.42
Total Current Assets	63.41	58.68	58.73	55.52	40.41	37.23
Property, Plant & Equipment	25.19	26.35	17.06	8.37	4.8	4.86
Long-Term Investments	0.27	0	0	0.25	0.25	0.25
Goodwill	-	17.56	17.56	2.75	2.75	2.75
Other Intangible Assets	23.56	3.74	3.15	2.45	2.43	1.98
Long-Term Deferred Tax Assets	1.18	1.52	1.31	1.24	0.85	0.66
Long-Term Deferred Charges	-	0.08	-	-	-	0
Other Long-Term Assets	1.98	4.5	2.36	0.77	0.22	1.14
Total Assets	115.6	112.44	100.16	71.36	51.71	48.86
Accounts Payable	15.73	13.66	14.89	8.49	6.38	7.74
Accrued Expenses	-	3.23	2.83	2.6	2.35	2.23
Short-Term Debt	-	0.63	-	-	-	-
Current Portion of Long-Term Debt	4.16	3.59	3.37	0.56	0.88	4.58
Current Portion of Leases	-	0.37	0.25	0.26	0.22	0.28
Current Income Taxes Payable	4.25	2.18	0.98	2.92	0.05	0.51
Current Unearned Revenue	-	2.45	2	1.26	0.8	0.43
Other Current Liabilities	3.91	1.55	1.48	0.66	0.47	0.51
Total Current Liabilities	28.05	27.65	25.79	16.75	11.14	16.27
Long-Term Debt	20.32	22.19	13.61	5	0.31	1.07
Long-Term Leases	-	1.24	0.5	0.53	0.25	0.47
Other Long-Term Liabilities	4.65	5.75	8.23	1.48	1.02	0.69
Total Liabilities	56.7	58.04	49.21	26.27	13.98	20.73
Common Stock	1.12	1.12	1.12	1.12	1.12	1.12
Retained Earnings	23.36	13.06	15.27	14	14.3	8.68
Comprehensive Income & Other	38.98	40.23	34.55	29.96	22.31	18.33
Shareholders' Equity	58.9	54.41	50.95	45.08	37.73	28.13
Total Liabilities & Equity	115.6	112.44	100.16	71.36	51.71	48.86
Total Debt	24.48	28.02	17.73	6.35	1.66	6.4
Net Cash (Debt)	-6.66	-2.9	9.14	27.59	19.14	12.42
Net Cash Growth	-	-	-66.89%	44.14%	54.06%	18.44%
Net Cash Per Share	-	-0.30	0.94	2.85	1.98	1.28
Filing Date Shares Outstanding	-	9.61	9.62	9.68	9.68	9.68
Total Common Shares Outstanding	-	9.61	9.64	9.68	9.68	9.68
Working Capital	35.36	31.03	32.94	38.77	29.26	20.95
Book Value Per Share	-	5.66	5.28	4.66	3.90	2.91
Tangible Book Value	35.34	33.11	30.24	39.88	32.55	23.41
Tangible Book Value Per Share	-	3.44	3.14	4.12	3.36	2.42
Land	-	20.42	0.75	0.64	0.64	0.64
Machinery	-	6.86	3.26	2.85	2.13	1.84
Construction In Progress	-	0.13	14.92	6.14	3.28	2.97

Source: S&P Capital IQ. Standard template. Financial Sources.